Novartis’ tone-deaf response to Michael Cohen: troubling but not surprising 

In the U.S., Novartis faces a trial next year for allegedly running afoul of kickback laws by holding thousands of “sham” events to entice doctors to prescribe its medicines. Three years ago, the company reached a $390 million settlement with authorities for inducing specialty pharmacies to boost prescriptions. In 2010, Novartis struck a $422 million settlement, partly for paying kickbacks to doctors.

View the most recent posts on Hobo Signs by Macdrifter or all of the posts in the archive.